A new national survey from Kenya highlights three critical findings that should inform TB control policy and practice. First, community stigma affects nearly seven in ten TB patients, making social discrimination the primary obstacle to treatment engagement. Second, stigma is not confined to communities—it manifests within healthcare facilities themselves, with 51% of patients experiencing discrimination from healthcare workers and systems. Third, women bear a disproportionate stigma burden, reporting four times higher rates than men. These evidence-based insights suggest that sustainable TB control improvements require integrated strategies addressing stigma at multiple levels: community awareness campaigns to counter misinformation, healthcare worker training to eliminate provider bias, and targeted support for vulnerable populations including women. Without deliberate stigma-reduction efforts, TB programs will continue facing preventable barriers to treatment adherence and cure.
Was this article helpful?
